title: Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals.
abstract: Pancreatic cancer (PC) is a major health problem. Conventional imaging modalities show limited accuracy for reliable assessment of the tumor. Recent researches suggest that molecular imaging techniques with tracers provide more biologically relevant information and are benefit for the diagnosis of the cancer. In addition, radiopharmaceuticals also play more important roles in treatment of the disease. This review summaries the advancement of the radiolabeled compounds in the theranostics of PC.
authors.affiliation: Yu-Ping Xu, Min Yang, Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, Jiangsu Province, China.
authors.forename: Yu-Ping
authors.initials: YP
authors.lastname: Xu
authors.affiliation: Yu-Ping Xu, Min Yang, Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, Jiangsu Province, China.
authors.forename: Min
authors.initials: M
authors.lastname: Yang
keywords: Diagnosis; Pancreatic cancer; Positron emission tomography; Radiopharmaceuticals; Therapy